Alzheimer's Stock Market Invest

Biopharmaceuticals
Athira Pharma Completes LIFT-AD Trial for Alzheimer's Treatment, Expects Results by Q3 2024 Jul 10, 2024
Companies
Cognition Therapeutics Reveals Key Pathways in Alzheimer's and Parkinson's Diseases via Sigma-2 Receptor Modulators Nov 15, 2023